Inventor

RIDEOUT JANET L

US53 patents

⚠️ This page may combine multiple inventors who share the name “RIDEOUT JANET L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIDEOUT JANET L

INSPIRE PHARMACEUTICALS INC

Method of treating dry eye disease with uridine triphosphates and related compounds

Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Therapeutic dinucleotide and derivatives

P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis

Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof

Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Method of treating dry eye disease with purinergic receptor agonists

Method of treating dry eye disease with purinergic receptor agonists

Method of treating otitis media with uridine triphosphates and related compounds

Method of treating gastrointestinal tract disease with purinergic receptor agonists

Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Method of treating bronchitis with uridine triphosphate and related compounds

Method of treating ciliary dyskinesia with uridine triphosphates and related compounds

Pharmaceutical compositions of uridine triphosphate

Dinucleoside polyphosphate compositions and their therapeutic use

Method of promoting cervical and vaginal secretions

Method of enhancing drainage of lacrimal system with purinergic receptor agonists

Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues

Method of treating dry eye disease with purinergic receptor agonists

Method of enhancing drainage of lacrimal system with purinergic receptor agonists

Method of treating dry eye disease with purinergic receptor agonists

P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis

BURROUGHS WELLCOME CO

Treatment of human viral infections

Treatment of human viral infections

Process for producing deoxyribosides using bacterial phosphorylase

Therapeutic nucleosides

Treatment of human viral infections

Treatment of human viral infections

Treatment of human viral infections

Treatment of human viral infections

Treatment of human viral infection

3&#39;-azido nucleoside compound

Anti-inflammatory deoxyribosides

Synthesis of ribosides using bacterial phosphorylase

Therapeutic nucleosides

Treatment of human viral infections

Treatment of feline viral infections

Treatment of human viral infections

Nucleoside and use thereof

Treatment of human viral infections

F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof

2-amino-6-(cyclopropylamino)purine-9-β-D-2&#39;,3&#39;-dideoxyribofuranoside and its pharmaceutically acceptable salts

Treatment of human viral infections

Pyrazolo pyrimidine riboside compounds, pharmaceutical compositions and method of use

UNIV NORTH CAROLINA

Uridine 5&#39;-diphosphate and analogs useful for treating lung diseases

Method of treating lung diseases with uridine 5&#39;-diphosphate and analogs thereof

Method of treating lung diseases with uridine 5′-diphosphate and analogs thereof

ALMOND MERRICK R

1-(β-D-xylofuranosyl)thymine derivatives

3'-azido nucleoside compound

2-amino-6-(cyclopropylamino)purine-9-β-D-2',3'-dideoxyribofuranoside and its pharmaceutically acceptable salts

Uridine 5'-diphosphate and analogs useful for treating lung diseases

Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof